✦ LIBER ✦

Efficacy and tolerability of once-daily quetiapine sustained release in patients with acute schizophrenia: A randomised, double-blind, 6-week, placebo-controlled study

✍ Scribed by R. Kahn; C. Schulz; V. Palazov; E. Reyes; D. Meulien; M. Brecher; O. Svensson; H.M. Andersson

Book ID: 118438179
Publisher: Elsevier Science
Year: 2007
Tongue: French
Weight: 47 KB
Volume: 22
Category: Article
ISSN: 0924-9338
DOI: 10.1016/j.eurpsy.2007.01.376

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised, placebo-controlled, relapse-

Randomised, placebo-controlled, relapse-prevention study with once-daily quetiapine sustained release in patients with schizophrenia

✍ J. Peuskens; J.K. Trivedi; S. Malyarov; M. Brecher; O. Svensson; F. Miller; I. P 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 47 KB

Safety and tolerability of once-daily ex

Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies

✍ Didier Meulien; Karin Huizar; Martin Brecher 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Introduction Extended release quetiapine fumarate (quetiapine XR) is a new formulation that allows once‐daily dosing and a titration regimen that is simpler than that of immediate release quetiapine (quetiapine IR) and may potentially increase patients' adherence to their prescribed

A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL COMPARING PALIPERIDONE ER AND QUETIAPINE IN PATIENTS WITH A RECENT ACUTE EXACERBATION OF SCHIZOPHRENIA

✍ Carla Canuso; Jennifer Carothers; Bryan Dirks; Young Zhu; Andreas Schreiner; Col 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Randomised, Double-Blind, Placebo-Contro

Randomised, Double-Blind, Placebo-Controlled Study on the Efficacy and Tolerance of Trospium Chloride in Patients with Motor Urge Incontinence

✍ Berthold Ulshöfer, Anja-Maria Bihr, Rolf-Hasso Bödeker, Dr Ulrich Schwantes, Han 📂 Article 📅 2001 🏛 Springer International Publishing AG 🌐 English ⚖ 176 KB

P.3.d.063 Lurasidone for maintenance of

P.3.d.063 Lurasidone for maintenance of efficacy in patients with schizophrenia: a double-blind, placebo-controlled, randomised withdrawal study

✍ Tandon, R.; Loebel, A.; Phillips, D.; Pikalov, A.; Hernandez, D.; Mao, Y.; Cucch 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Efficacy, safety, and tolerability of du

Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study

✍ Hee Chul Eun; Oh Sang Kwon; Je Ho Yeon; Hyo Seung Shin; Byung Yoon Kim; Byung In 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 555 KB